Fresenius Medical Care Derby is a medicare approved dialysis facility center in Derby, Kansas and it has 12 dialysis stations. It is located in Sedgwick county at 712 Klein Circle, Derby, KS, 67037. You can reach out to the office of Fresenius Medical Care Derby at (316) 788-1434. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Medical Care Derby has the following ownership type - Profit. It was first certified by medicare in May, 2012. The medicare id for this facility is 172552 and it accepts patients under medicare ESRD program.
| Name | Fresenius Medical Care Derby |
|---|---|
| Location | 712 Klein Circle, Derby, Kansas |
| No. of Dialysis Stations | 12 |
| Medicare ID | 172552 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 712 Klein Circle, Derby, Kansas, 67037 | |
| (316) 788-1434 | |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
| NPI Number | 1649567629 |
| Organization Name | Fresenius Medical Care Derby |
| Doing Business As | Fms Midwest Dialysis Centers Llc |
| Address | 712 Klein Circle Derby, Kansas, 67037 |
| Phone Number | (316) 788-1434 |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 19 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 11 |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 31 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 285 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fresenius Medical Care Derby with elevated calcium levels.
| Patients with hypercalcemia | 32 |
| Hypercalcemia patient months | 291 |
| Patients with Serumphosphor | 34 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 32 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 44 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 12 |
| Patients with Serumphosphor greater than 7 mg/dL | 3 |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 33 |
| Patient months included in arterial venous fistula and catheter summaries | 234 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 58 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 9 |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 26 |
| Hospitalization Rate in facility | 94.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 258.6 |
| Hospitalization Rate: Lower Confidence Limit | 37.5 |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Fresenius Medical Care Derby were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 10.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 32.2 |
| Readmission Rate: Lower Confidence Limit | 1.5 |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fresenius Medical Care Derby get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.26 (As Expected) |
| SIR: Upper Confidence Limit | 4.15 |
| SIR: Lower Confidence Limit | .21 |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fresenius Medical Care Derby's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 21 |
| Transfusion Rate in facility | 13 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 157.7 |
| Transfusion Rate: Lower Confidence Limit | 1.4 |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Fresenius Medical Care Derby lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 118 |
| Mortality Rate in facility | 15.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24.5 |
| Mortality Rate: Lower Confidence Limit | 8.9 |
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago
News Archive
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.
A Senate Foreign Relations Committee report, written by two Senate staffers, who just returned from Haiti where they assessed relief efforts, draws attention to "immediate shelter and sanitation concerns" and voices "concern about the coordination of Washington's U.S. government response to Haiti," Politico's Laura Rozen writes on her blog. A link to the text of the report appears on Politico's Web site.
A study from Sydney University's Centre for Health Services based at Westmead Hospital, has shown that more than one in 10 operations over a six month period were cancelled at the last minute.
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Maine Gov. John Baldacci (D) on Wednesday signed into law a bill that increases taxes and fees on beer, wine and soda manufacturers to fund the Dirigo Health program, the Blethen Maine News Service/Portland Press Herald reports.
› Verified 2 days ago